Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 2 5Phase 3 2Phase NA 1Phase 2/3 1Phase 1/2 1

Status

Completed 5

Sponsor Class

INDUSTRY 3OTHER 1NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 2Genitourinary 2Breast 1

Conditions

Prostatic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Neoplasm Metastasis 1Lung Neoplasms 1Breast Neoplasms 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × satraplatin × Clear all
NCT00634647 2018-10-02

Satraplatin and Prednisone to Treat Prostate Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
24 enrolled 12 charts
Genitourinary

Prostatic Neoplasms

NCT01289067 2018-02-13

Utilizing A Genomic Sig for "BRCAness" to Eval the Efficacy of Satraplatin in Men With Met. Castration Resistant Prostate Ca

Icahn School of Medicine at Mount Sinai

Phase 2 Completed
13 enrolled 8 charts
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT00370383 2012-08-07

A Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC)

Agennix

Phase 2 Completed
100 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00268970 2012-04-30

Satraplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer

Agennix

Phase 2 Completed
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00265655 2012-03-28

Satraplatin for Patients With Metastatic Breast Cancer (MBC)

Agennix

Phase 2 Completed
40 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡